Background Children with steroid resistant nephrotic syndrome
Reprint requests to: Partini P Trihono, Consultant of Pediatric Nephrology, Department of Child Health, University of Indonesia Medical partinipt@yahoo.com N ephrotic syndrome (NS) is the most common manifestation of glomerulopathy in children. Based on patient response to steroid treatment, NS is divided into two types: steroid-sensitive nephrotic syndrome (SSNS) and steroid-resistant nephrotic syndrome (SRNS). Steroid resistance nephrotic syndrome is Hospital, Jakarta. [3] [4] [5] [6] Children with SRNS generally have good survival rates, although during the course of the disease they may develop decreased kidney function, leading to a condition where the kidney function is not compatible with life, called endstage renal disease (ESRD). In children with SRNS, the risk of progression to ESRD is high, reaching
Previous studies have shown a
There has been little data on the survival of children with SRNS published in Indonesia.
We aimed to determine the life and kidney survival rates of children with SRNS at the first, second, third, fourth and fifth years after onset. We also assessed the effects of several potential prognostic factors for survival, such as age at onset, initial kidney function, hypertension at onset, and type of resistance, in children with SRNS. Data on survival rates may help us better manage SRNS patients, educate patients on prognosis, and also provide a basis for further study.
Methods
secondary data obtained from medical records of SRNS patients registered in Department of Child Health, Cipto Mangunkusumo Hospital, between months. Patients with incomplete medical records were excluded. Dependent variables were event of death, as well as the occurence of a doubling of base creatinine levels and ESRD (defined as glomerular filtration rate < ). Independent variables were age at SRNS onset, initial kidney function, hypertension at was divided into stages of chronic kidney disease. Stages of chronic kidney disease (CKD) from I-V were defined as glomerular filtration rates (calculated by Schwartz (or requiring routine dialysis), respectively. Hypertension was categorized as with or without hypertension at the time of onset. Type of resistance was defined as primary or secondary resistance.
The total sample size was estimated by multiplying not routinely visit the Pediatric Nephrology clinics had home visits to determine their survival status. Those with incomplete kidney function data had their kidney were classified as having normal or decreased kidney function, died, or lost to follow-up (defined as patients whose status could not be determined until the end of the study period). Kaplan-Meier curves were constructed for each of the outcomes, followed by bivariate analysis to identify any associations between the variables. Survival curves that fulfilled the proportional hazard assumption were analyzed by time-independent Cox regression analysis, while those that did not fulfill the requirement were analyzed by time-dependent Cox regression. Multivariate analysis was further statistical analyses were performed using the IBM-SPSS program version 19. This study was approved by the Ethics Commitee of the University of Indonesia a complete explanation of the study. Subjects' parents provided written informed consents. Table 1 .
in stage IV-V (Table 2 ).
Life Survival Rates
while the other two died of unknown causes. The Figure 2 ). Survival was further described according to prognostic factors of initial kidney function, age at onset, type of resistance, and hypertension at time of onset.
The five-year survival of patients with initial respectively, with no significant difference between Primary and secondary steroid-resistant NS patients
Multivariate analysis could not be performed since not all variables fulfilled the proportional hazard assumption. In addition, there was no variables with 
Kidney Survival Rates
Kidney survival was determined by two measurements: lack of doubling of base creatinine levels and lack of ESRD. The median time of follow up for kidney refused to have blood test for kidney function, while in the other 11 patients, the most recent kidney function was obtained from the outpatient clinic data of their last visit. Based on recent kidney function, this study revealed that 5 of 36 patients with CKD stage I at onset, 1 of 6 patients with CKD stage II at onset, while no patients with CKD stage III at onset, developed ESRD.
Kidney survival expressed as a lack of doubling of The median of age at onset of our subjects was 5.1 years, similar to those in previous studies. There also similar to previous studies.
than that previously reported. This may be attributed to several factors, such as the differences in treatment given. Patients in this study were initially given et al. has not been used for SRNS treatment routinely due to its relatively high price and the technical treatment was similar to that of a prospective study by Oluwu et al intravenous dexamethasone was followed by oral 9 Sepsis and organ failure as causes of death were similar to those of other study, though the proportion was higher in our study. Kidney survival may also have been affected by infectious causes, since SRNS patients were immunocompromised and prone to infection, although we did not review this factor in our study. In fact, the deaths of SRNS patients were caused by many factors.
Children with CKD stage I at SRNS onset had better survival than the other stage groups, although the differences were not statistically significant. This result may be due to the small number of subjects in each group. Differences in median survival between the CKD stage I, II, and III groups was also not Mekahli et al. who reported that kidney function at disease onset did not contribute to survival.
Based on age at onset, the decrease in survival statistically significant difference between these two groups may be due to the small number of subjects.
response to treatment with immunosuppressive drugs. Survival of the secondary resistance group was better than that of the primary group, although not statistically significant, which may be due to the difference in proportion and small sample size. Similar results were found by other studies who showed that the primary resistance group had a worse prognosis than that of the secondary resistance group. Oluwu et al. found that the primary resistance group had mostly histopathologic types of focal segmental glomerulosclerosis (FSGS). 9 We did not examine the histopathology of the children's kidneys to evaluate for FSGS, as kidney biopsy is not performed routinely in our hospital. Some studies reported that children with primary resistance or FSGS have better outcome Survival of children with hypertension at disease onset was not significantly different than those without hypertension, similar to the study by Mekahli et al. Larger sample size and longer prospective follow up time may be needed to study the effect of hypertension on survival.
group. 13 Kidney survival in the fourth year, as measured by the lack of doubling of base creatinine
et al
Based on initial kidney function, there was no differences in kidney survival as measured by the doubling of base creatinine levels, possibly be due out of the 3 patients in the CKD stage III group had routine visits, compared to 3 of 6 patients in CKD stage II, possibly resulting in better kidney survival in CKD stage III. On the other side, based on the age better kidney survival as measured by the doubling of base creatinine, although the difference was not statistically significantly from the group with age at onset of > sample sizes of the groups.
We found that the type of resistance did not contribute to kidney survival based on the lack of doubling of creatinine levels, in contrast to the study by Otukesh et al. Furthermore, Mekahli et al. found that there was no differences in kidney survival between the hypertensive groups, similar to our findings. However, Fomina et al. observed that hypertension was a prognostic factor for reduction of kidney function in children with SRNS.
by the end of our study, fewer than reported by Mekahli et al Kidney survival based on the that of Mekahli et al. who reported a kidney survival of However, in the fourth year, our kidney survival rate was higher than that of Oluwu et al 9 These differences may be due to the treatment regimen the proportion of children with primary resistance developing ESRD was higher than that of the In our study, kidney survival based on lack of ESRD was not influenced by the initial kidney function, similar to results from Mekahli et al. Differences in sample size between groups and patient compliance may have affected this result. We also had better prognoses for kidney survival based on lack different from the other group, it was consistent with the results of Mekahli et al. et al. concluded that the type of resistance influenced the response to immunosuppressant therapy. They found that the secondary resistance group had better prognoses, resistance group. We found that the secondary resistance group also had better kidney survival resistance group, although this difference was not statistically significant.
We found no significant differences in the hypertension at disease onset groups, similar to the results of Mekahli et al. Median kidney survival of the hypertensive group was 36 months, while that result may be due to the differences in time of follow we addressed only hypertension at disease onset, while hypertension during the course of disease may have further contributed to the development of ESRD.
with SRNS that was not included in our study was type of histopathology noted from kidney biopsy was associated with the outcome of SRNS. 15 In Indonesia, kidney biopsy is not routinely performed in the management of SRNS.
In conclusion, children with SRNS are prone to develop a doubling of base creatinine levels and ESRD. Overall survival of children with SRNS in our study is low. Prognostic factors such as initial kidney function, age at onset, type of resistance, and hypertension at disease onset do not contribute to both patient survival and kidney survival of children with SRNS. 
